Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Jacob

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Advances in Therapy|June 17, 2010
Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap?Manuel Serrano-Gil, Stephan Jacob
Advances in Therapy|September 17, 2010
Engaging and empowering patients to manage their type 2 diabetes, Part II: Initiatives for successStephan Jacob, Manuel Serrano-Gil
Cardiovascular Endocrinology & Metabolism|August 18, 2020
The future of cardiovascular and metabolic medical practice: evidence-based winds of changeAndrew J Krentz, Stephan Jacob
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|September 7, 2020
Cardiovascular outcome trials in obesity: A reviewJohn P H Wilding, Stephan Jacob
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2006
[We need interdisciplinary vessel-centered medicine]Jürgen Ennker, Stephan Jacob, Achim H Lauruschkat
Cardiovascular Endocrinology & Metabolism|February 13, 2023
Prioritizing obesity treatment: expanding the role of cardiologists to improve cardiovascular health and outcomesDonna H Ryan, John E Deanfield, Stephan Jacob
Journal of Diabetes Science and Technology|July 9, 2016
Usability Evaluation of a Blood Glucose Monitoring System With a Spill-Resistant Vial, Easier Strip Handling, and Connectivity to a Mobile App: Improvement of Patient Convenience and SatisfactionCraig Harvey, Richard Koubek, Vanessa Bégat, et al.
Cardiovascular Endocrinology & Metabolism|September 15, 2025
Improved cardiovascular outcomes with glucagon-like peptide-1 receptor agonists - what is the role of weight reduction?Stephan Jacob, Robert H Eckel, Andrew J Krentz
Cardiorenal Medicine|January 20, 2012
Effects of Chronic Antagonism of Endocannabinoid-1 Receptors on Glucose Tolerance and Insulin Action in Skeletal Muscles of Lean and Obese Zucker RatsKatherine A Lindborg, Stephan Jacob, Erik J Henriksen
Drugs|July 24, 2021
Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of CareStephan Jacob, Andrew J Krentz, John Deanfield, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Advances in Therapy|June 17, 2010
Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap?Manuel Serrano-Gil, Stephan Jacob
Advances in Therapy|September 17, 2010
Engaging and empowering patients to manage their type 2 diabetes, Part II: Initiatives for successStephan Jacob, Manuel Serrano-Gil
Cardiovascular Endocrinology & Metabolism|August 18, 2020
The future of cardiovascular and metabolic medical practice: evidence-based winds of changeAndrew J Krentz, Stephan Jacob
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|September 7, 2020
Cardiovascular outcome trials in obesity: A reviewJohn P H Wilding, Stephan Jacob
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2006
[We need interdisciplinary vessel-centered medicine]Jürgen Ennker, Stephan Jacob, Achim H Lauruschkat
Cardiovascular Endocrinology & Metabolism|February 13, 2023
Prioritizing obesity treatment: expanding the role of cardiologists to improve cardiovascular health and outcomesDonna H Ryan, John E Deanfield, Stephan Jacob
Journal of Diabetes Science and Technology|July 9, 2016
Usability Evaluation of a Blood Glucose Monitoring System With a Spill-Resistant Vial, Easier Strip Handling, and Connectivity to a Mobile App: Improvement of Patient Convenience and SatisfactionCraig Harvey, Richard Koubek, Vanessa Bégat, et al.
Cardiovascular Endocrinology & Metabolism|September 15, 2025
Improved cardiovascular outcomes with glucagon-like peptide-1 receptor agonists - what is the role of weight reduction?Stephan Jacob, Robert H Eckel, Andrew J Krentz
Cardiorenal Medicine|January 20, 2012
Effects of Chronic Antagonism of Endocannabinoid-1 Receptors on Glucose Tolerance and Insulin Action in Skeletal Muscles of Lean and Obese Zucker RatsKatherine A Lindborg, Stephan Jacob, Erik J Henriksen
Drugs|July 24, 2021
Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of CareStephan Jacob, Andrew J Krentz, John Deanfield, et al.
Pageof 5